Frequency of thalassemia carrier and Hb variant and the quality of stored donor blood

  • Eva A. Maharani Health polytechnic of Jakarta 3, Ministry of Health. Master Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Yuyun S.M. Soedarmono Department of Science Transfusion, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Ita M. Nainggolan Eijkman Institute for Molecular Biology, Jakarta
Keywords: donors, Hb variant, hemolytic rate, thalassemia carier
Abstract viewed: 1852 times
PDF downloaded: 520 times

Abstract

Background: This study was aimed to determine the frequency of thalassemia and Hb variant in blood donor. In addition, we also wanted to know the quality of blood from the donor up to seven days of storage, by calculating percentage of hemolysis in vitro.

Methods: This cross-sectional study was conducted on 138 blood donor specimens at Red Cross Blood Centre Unit in Jakarta. All specimens were tested for thalassemia and Hb variant by complete blood count (CBC) and Hb analysis with HPLC method and DNA analysis for the detection of α thalassemia carrier. To analyze the quality of stored blood, the calculation of hemolytic rate of red blood cells (RBCs) on whole blood (WB) was compared between the first and seventh days of storage.

Results: Out of the 138 specimens, 5 samples (3.6%) were diagnosed for α thalassemia carrier in which, one of them is co-inherited with ovalositosis hereditary (Southeast Asian Ovalositosis/SAO), 3 samples (2.2%) for β thalassemia carrier, and 3 samples (2.2%) for Hb E. Meanwhile, the hemolytic rates of RBCs on WB in first day and seven day of storage were below one percent.

Conclusion: The frequency of thalassemia carrier and Hb variants in blood donors at Red Cross Blood Centre Unit in Jakarta was 8%. The quality of stored blood until seven day of storage was quite good.

References

  1. Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011;134(4):498-506. http://dx.doi: 10.3109/03630269709000664

  2. Rathod DA, Kaur A, Patel V, Patel K, Kabrawala R, Patel V, et al. Usefulnes of cell counter-based and formulas in detection of β-thalasemia trait in areas of high prevalence. Am J Clin Pathol. 2007;128(4):585-9. http://dx.doi.org/10.1309/R1YL4B4BT2WCQDGV

  3. Setianingsih I, Harahap A, Nainggolan IM. Alpha thalassemia in Indonesia: phenotypes and molecular defects. Adv Exp Med Biol. 2003;531:47-56. http://dx.doi.org/10.1007/978-1-4615-0059-9_4

  4. Lanni F, Gani RA, Widuri, Rochdiyat W, Verawaty B, Sukmawati, et al. β-thalassemia and hemoglobin-E traits in Yogyakarta population. Presented in 11th International Conference on Thalasemia and Haemoglobinopathies & 13rd International TIF Conference for Thalasemia patients and parents. Singapore; 8-11 Oktober 2008.

  5. Klein HG, Anstee DJ. Mollison's blood transfusion in clinical medicine. 11th ed. United Kingdom: Blackwell Publishing; 2005. http://dx.doi.org/10.1002/9780470986868

  6. Brecher ME, editor. Technical manual. The United States: AABB; 2005. p. 97-115.

  7. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of hemoglobin: Genetics, Patophysiology, and clinical management. 2nded. New York: Cambridge University Press; 2009. http://dx.doi.org/10.1017/CBO9780511596582

  8. Alabdulaali MK, Alayed KM, Alshaikh AF, Almashhadani SA. Prevalence of glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among blood donors in Riyadh. Asian J transfus Sci. 2010;4(1):31-3. http://dx.doi.org/10.4103/0973-6247.59389

  9. Gkoumassi E, Dijkstra-Tiekstra MJ, Hoentjen D, de Wildt-Eggen J. Hemolysis of red blood cells during processing and storage. Transfusion AABB. 2012;52(3):489-92. http://dx.doi.org/10.1111/j.1537-2995.2011.03298.x

  10. Kohne E. Hemoglobinopathies: clinical manifestation, diagnosis, and treatment. Dtsch Arztebl Int. 2011;108(31-32):532-40. http://dx.doi: 10.3238/arztebl.2011.0532

  11. Nainggolan IM, Dewi M, Suryatenggara AN. Buku praktikum diagnosis molekul thalassemia. Jakarta: Lembaga biologi molekuler Eijkman; 2007. Indonesian.

  12. Weatherall D. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian J Med Res. 2011;134(4):493-7.

  13. Vichinsky E. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program. 2007:79-83. http://dx.doi.org/10.1182/asheducation-2007.1.79

  14. Laosombat V, Viprakasit V, Dissaneevate S, Leetanaporn R, Chotsampancharoen T, Wongchanchailert M, et al. Natural history of southeast Asian Ovalocytosis during the first 3 years of life. Blood Cells Mol Dis. 2010;45(1):29-32. http://dx.doi.org/10.1016/j.bcmd.2010.03.010

  15. Sowemimo-coker SO. Red blood cell hemolysis during processing. Transfus Med Rev. 2002;16(1):46-60. http://dx.doi.org/10.1053/tmrv.2002.29404

  16. Zimmermann R, Heidenrich D, Weisbach V, Zingsem J, Neidhardt B, Eickstein R. In vitro quality control of red blood cells concentrate outdated in clinical practice. Transfus Clin Biol. 2003;10(4):275-83. http://dx.doi.org/10.1016/S1246-7820(03)00032-6

Published
2015-01-27
How to Cite
1.
Maharani EA, Soedarmono YS, Nainggolan IM. Frequency of thalassemia carrier and Hb variant and the quality of stored donor blood. Med J Indones [Internet]. 2015Jan.27 [cited 2019Dec.15];23(4):209-12. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/766
Section
Clinical Research